Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64,037 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Human neutralizing antibodies elicited by SARS-CoV-2 infection.
Ju B, Zhang Q, Ge J, Wang R, Sun J, Ge X, Yu J, Shan S, Zhou B, Song S, Tang X, Yu J, Lan J, Yuan J, Wang H, Zhao J, Zhang S, Wang Y, Shi X, Liu L, Zhao J, Wang X, Zhang Z, Zhang L. Ju B, et al. Among authors: zhang l, zhang s, zhang q, zhang z. Nature. 2020 Aug;584(7819):115-119. doi: 10.1038/s41586-020-2380-z. Epub 2020 May 26. Nature. 2020. PMID: 32454513
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry.
Ge J, Wang R, Ju B, Zhang Q, Sun J, Chen P, Zhang S, Tian Y, Shan S, Cheng L, Zhou B, Song S, Zhao J, Wang H, Shi X, Ding Q, Liu L, Zhao J, Zhang Z, Wang X, Zhang L. Ge J, et al. Among authors: zhang l, zhang s, zhang q, zhang z. Nat Commun. 2021 Jan 11;12(1):250. doi: 10.1038/s41467-020-20501-9. Nat Commun. 2021. PMID: 33431856 Free PMC article.
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies.
Yan R, Wang R, Ju B, Yu J, Zhang Y, Liu N, Wang J, Zhang Q, Chen P, Zhou B, Li Y, Shen Y, Zhang S, Tian L, Guo Y, Xia L, Zhong X, Cheng L, Ge X, Zhao J, Wang HW, Wang X, Zhang Z, Zhang L, Zhou Q. Yan R, et al. Among authors: zhang l, zhang s, zhang q, zhang z, zhang y. Cell Res. 2021 May;31(5):517-525. doi: 10.1038/s41422-021-00487-9. Epub 2021 Mar 17. Cell Res. 2021. PMID: 33731853 Free PMC article.
Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.
Wang R, Zhang Q, Ge J, Ren W, Zhang R, Lan J, Ju B, Su B, Yu F, Chen P, Liao H, Feng Y, Li X, Shi X, Zhang Z, Zhang F, Ding Q, Zhang T, Wang X, Zhang L. Wang R, et al. Among authors: zhang l, zhang r, zhang q, zhang f, zhang t, zhang z. Immunity. 2021 Jul 13;54(7):1611-1621.e5. doi: 10.1016/j.immuni.2021.06.003. Epub 2021 Jun 8. Immunity. 2021. PMID: 34166623 Free PMC article.
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2.
Zhang Q, Ju B, Ge J, Chan JF, Cheng L, Wang R, Huang W, Fang M, Chen P, Zhou B, Song S, Shan S, Yan B, Zhang S, Ge X, Yu J, Zhao J, Wang H, Liu L, Lv Q, Fu L, Shi X, Yuen KY, Liu L, Wang Y, Chen Z, Zhang L, Wang X, Zhang Z. Zhang Q, et al. Among authors: zhang l, zhang s, zhang z. Nat Commun. 2021 Jul 9;12(1):4210. doi: 10.1038/s41467-021-24514-w. Nat Commun. 2021. PMID: 34244522 Free PMC article.
Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.
Li M, Guo J, Lu S, Zhou R, Shi H, Shi X, Cheng L, Liang Q, Liu H, Wang P, Wang N, Wang Y, Fu L, Xing M, Wang R, Ju B, Liu L, Lau SY, Jia W, Tong X, Yuan L, Guo Y, Qi H, Zhang Q, Huang Z, Chen H, Zhang Z, Chen Z, Peng X, Zhou D, Zhang L. Li M, et al. Among authors: zhang l, zhang q, zhang z. Front Immunol. 2021 Jun 28;12:697074. doi: 10.3389/fimmu.2021.697074. eCollection 2021. Front Immunol. 2021. PMID: 34262569 Free PMC article.
A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.
Shan S, Mok CK, Zhang S, Lan J, Li J, Yang Z, Wang R, Cheng L, Fang M, Aw ZQ, Yu J, Zhang Q, Shi X, Zhang T, Zhang Z, Wang J, Wang X, Chu JJH, Zhang L. Shan S, et al. Among authors: zhang l, zhang s, zhang q, zhang t, zhang z. Front Immunol. 2021 Dec 13;12:766821. doi: 10.3389/fimmu.2021.766821. eCollection 2021. Front Immunol. 2021. PMID: 34966387 Free PMC article.
Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2.
Ji Y, Zhang Q, Cheng L, Ge J, Wang R, Fang M, Mucker EM, Chen P, Ma J, Zhang R, Li C, Hammond H, Baracco L, Holbrook M, Frieman M, Zhang Z, Wang X, Hooper JW, Zhang L, Zhu Q. Ji Y, et al. Among authors: zhang l, zhang r, zhang q, zhang z. Front Immunol. 2022 Sep 14;13:980435. doi: 10.3389/fimmu.2022.980435. eCollection 2022. Front Immunol. 2022. PMID: 36189212 Free PMC article.
64,037 results
You have reached the last available page of results. Please see the User Guide for more information.